Quote from ECDC Director Dr. Andrea Ammon as ECDC publishes a threat assessment brief on the implications of the spread of the Delta variant of concern for the EU/EEA.
Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta ( B.1.617.2 ) variant of concern
The aim of this threat assessment brief is to assess potential public health implications of the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) for the European Union and European Economic Area (EU/EEA).
On 22 June 2021, the European Centre for Disease Prevention and Control (ECDC) launches the European surveillance portal for infectious diseases (EpiPulse), an online portal for European public health authorities and global partners to collect, analyse, share, and discuss infectious disease data for threat detection, monitoring, risk assessment and outbreak response.
Memorandum of understanding to foster cooperation between Mexico and ECDC in prevention and control of infectious diseases
The European Centre for Disease Prevention and Control (ECDC) and the Ministry of Health of Mexico are signing today a Memorandum of Understanding (MoU) that will facilitate close collaboration between ECDC and Mexico in working jointly to protect the health of the citizens of the European Union and Mexico.
ECDC and The European Union Aviation Safety Agency (EASA) today issued a new version of the Aviation Health Safety Protocol providing clear operational guidance and risk-based recommendations for health-safe air travel to complement the European Union’s initiatives, such as the EU Digital COVID Certificates.
ECDC and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) have launched a number of activities to help strengthen EU/EEA Member States’ capacity for detection of SARS-CoV-2 variants in the shorter and longer term. These activities are one of five action areas of the ‘HERA Incubator’, a new EU bio-defence preparedness plan against SARS-CoV-2 variants launched by the European Commission on 17 February 2021.
The month-long European football competition will see 24 teams playing for the top European prize across eleven host countries, observed by some 460 000 spectators. ECDC has already begun enhanced epidemic intelligence activities to monitor the Championship and help keep it safe.
Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update
This report assesses SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA.
A new ECDC report, issued today, provides policymakers in EU/EEA with a number of objectives and considerations on COVID-19 vaccination of 12-18-year-olds. The report highlights the current recommendations and status of COVID-19 vaccination of adolescents in EU/EEA countries, describes the epidemiology of COVID-19 in this age group and discusses vaccine effectiveness against transmission of SARS-CoV-2.
This year celebrates 15 years of successful cooperation between the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe, at a time when COVID-19 continues to underscore the importance of establishing strong partnerships.
A new dashboard provides an overview of the proportion of SARS-CoV-2 variants of concern and variants of interest among sequenced samples in EU/EEA countries, as well as sequencing volumes.
In the latest episode of the “European Health Union Now!” podcast, ECDC Director Andrea Ammon discusses a strengthened and potentially extended mandate for ECDC with Dorli-Kahr Gottlieb, Secretary General of the European Health Forum Gastein.
Threat Assessment Brief: Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA
The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage B.1.617.2.
Europe Day, celebrated each year on 9 May, marks the anniversary of the Schuman Declaration.
ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.
This document assesses the risk related to dengue for EU/EEA citizens travelling to or residing in Réunion, and the risk related to having an outbreak of dengue in mainland EU/EEA following introduction of the virus from Réunion.
Each year on 5 May, the “SAVE LIVES: Clean Your Hands” campaign takes place as part of a major global effort led by the World Health Organization to mobilise people around the world to increase adherence to hand hygiene in all healthcare settings, thus protecting healthcare workers and patients from healthcare-associated infections caused by various pathogens.
Since the discovery of SARS-CoV-2, three variants of concern (VOC), first identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1), have been associated with higher transmissibility and severity of disease, with potential implications for acquired immunity or the effectiveness of current vaccines.
The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) today kicked off a new initiative aimed at strengthening post-marketing monitoring of the safety, effectiveness and impact of COVID-19 vaccines in the EU/EEA.
European Immunization Week (EIW) is marked across the European Region every year in the last week of April. It aims to raise awareness of the importance of immunisation for people’s health and well-being.